CNS remyelination: from mechanisms to medicines

Update: 2016-10-07

Description

NDCN Departmental Seminar

Comments

In Channel

Lung protective ventilation based on physics and physiology

2020-02-2401:02:21

Eye movements and cognitive function in Parkinson’s disease

2017-09-2943:58

Kate Binnie: First and Last Breath soundscape

2017-08-0403:59

Saturday Scientist, BBC Radio Oxford

2017-08-0302:18

Cell transplants to treat the 'disease' of chronic pain

2017-04-1001:16:58

Detecting, tracking, and predicting motor neuron disease

2017-03-0652:53

Forty years on: from frogs to man

2016-12-0801:03:01

CNS remyelination: from mechanisms to medicines

2016-10-0748:07

Functional imaging of dyskinesia in Parkinson’s disease

2016-06-1632:56

Defining the genetic architecture of Alzheimer’s disease

2016-05-1640:36

The Glymphatic System

2016-04-0153:15

Advanced imaging of the spinal cord in multiple sclerosis

2016-04-0145:14

How do risk genes for psychosis operate?

2016-03-0446:20

The tempos of perception in the human brain

2016-01-0559:38

Human enhancement: the future of neuroscience

2015-12-0252:05

From touch to pain: making sense of sensation

2015-11-2056:05

Management of primary lateral sclerosis (PLS) symptoms

2015-11-1030:30

Techniques used to research primary lateral sclerosis (PLS)

2015-11-1017:09

The genetics of primary lateral sclerosis (PLS)

2015-11-1016:40

What is Primary Lateral Sclerosis (PLS)?

2015-11-1016:34

00:00

CNS remyelination: from mechanisms to medicines

#box-pro-ellipsis-17573706939450{-webkit-line-clamp:2;}CNS remyelination: from mechanisms to medicines

CNS remyelination: from mechanisms to medicines

Robin Franklin

CNS remyelination: from mechanisms to medicines